MARC Record from marc_openlibraries_sanfranciscopubliclibrary

LEADER: 02312pam a2200565 a 4500
001 53331686
003 OCoLC
005 20151005043211.0
008 031015s2004 nyu b 001 0beng
010 $a2003056983
016 7 $a101206189$2DNLM
020 $a0060555564
035 $a53331686
040 $aDLC$cDLC$dYDX$dNLM$dSFR$dUtOrBLW
042 $apcc
043 $an-us---
049 $aSFRA
050 00 $aHD9675.A672$bW35 2004
060 00 $a2004 B-544
060 10 $aQV 269$bP971c 2004
082 00 $a338.7/61616994061/092$aB$222
092 $a338.7616$bP951c
100 1 $aPrud'homme, Alex.
245 14 $aThe cell game :$bSam Waksal's fast money and false promises--and the fate of ImClone's cancer drug /$cAlex Prud'homme.
246 30 $aSam Waksal's fast money and false promises--and the fate of ImClone's cancer drug
260 $aNew York :$bHarperBusiness,$cc2004.
300 $axviii, 412 p. ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references (p. 369-392) and index.
600 10 $aWaksal, Samuel David.
610 20 $aImClone Systems Incorporated$xHistory.
650 0 $aBusinessmen$zUnited States$vBiography.
650 0 $aAntineoplastic agents industry$xCorrupt practices$zUnited States.
650 0 $aMonoclonal antibodies$xResearch$zUnited States$xHistory.
650 0 $aCancer$xChemotherapy.
650 0 $aDrugs$zUnited States$xTesting.
650 0 $aInsider trading in securities$zUnited States.
907 $a.b1885820x$b12-20-18$c06-02-04
998 $axbt$b06-21-07$cm$da $e-$feng$gnyu$h4$i2
957 00 $aOCLC reclamation of 2017-18
907 $a.b1885820x$b12-02-14$c06-02-04
956 $aPre-reclamation 001 value: ocm53331686
994 $aX0$bSFR
998 $axbt$b06-21-07$cm$da$e-$feng$gnyu$h4$i2
999 $yMARS
998 $axbt$b06-02-04$cm$da$e-$feng$gnyu$h4$i1
945 $a338.7616$bP951c$d - - $e09-19-2007 19:29$f0$g0$h10-31-07$i31223049168298$j221$0800$k - - $lxbtci$o-$p$24.95$q-$r-$s- $t0$u3$v1$w0$x0$y.i38218975$z07-06-04
945 $a338.7616$bP951c$d - - $e05-03-2018 16:55$f0$g0$h07-25-18$i31223049168207$j501$0800$k - - $lxbtci$o-$p$24.95$q-$r-$s- $t0$u4$v8$w0$x1$y.i38218987$z07-06-04